IDEXX director converts 101 RSUs into common shares
IDEXX Laboratories director Karen Peacock reported a routine equity compensation event.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IDEXX Laboratories director Karen Peacock reported a routine equity compensation event. On May 7, 2026, she exercised 101 Restricted Stock Units, receiving 101 shares of common stock at an exercise price of $0.00 per share. Following this vesting and conversion, she directly holds 102 shares of common stock. No shares were sold and no tax-withholding dispositions were reported in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 101 | $0.00 | $0.00 |
| Exercise | Common Stock | 101 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock that vested in one installment on May 7, 2026.
- F2. Not applicable.
Key Figures
Key Terms
Restricted Stock Unit financial
derivative security financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IDEXX (IDXX) director Karen Peacock report?
What are Karen Peacock’s IDEXX (IDXX) holdings after the reported transaction?
Was the IDEXX (IDXX) Form 4 transaction a market purchase or sale?
What do the Restricted Stock Units in the IDEXX (IDXX) Form 4 represent?
AI-generated analysis. How Rhea-AI works. Not financial advice.